Lower vitamin D levels in surgical hyperparathyroidism versus thyroid patients

American Surgeon

Volumn 80, Issue 5, 2014, Pages 505-510

  Lindeman, Brenessa M ^a   Pesce, Catherine E ^a   Tsai, Hua Ling ^a   Somervell, Helina ^a   Umbricht, Christopher B ^a   Kowalski, Jeanne ^a   Zeiger, Martha A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D; 25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; DRUG DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; PARATHYROIDECTOMY; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; PROSPECTIVE STUDY; SECONDARY HYPERPARATHYROIDISM; TERTIARY HYPERPARATHYROIDISM; THYROID DISEASE; THYROIDECTOMY; VERY ELDERLY; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; PREOPERATIVE PERIOD; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; LINEAR MODELS; MALE; MIDDLE AGED; PARATHYROIDECTOMY; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES; THYROID DISEASES; THYROIDECTOMY; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84904538886     PISSN: 00031348     EISSN: 15559823     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Akerstrom GLS, Lundren E. Natural history of untreated primary hyperparathyroidism. In: Clark OH, Duh QY, eds. Textbook of Endocrine Surgery. Philadelphia, PA: W.B. Saunders Company; 1997:303-10.
2. Ozbey N, Erbil Y, Ademoglu E, et al. Correlations between vitamin D status and biochemical/clinical and pathological parameters in primary hyperparathyroidism. World J Surg 2006;30:321-6.
3. Kantorovich V, Gacad MA, Seeger LL, et al. Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism. J Clin Endocrinol Metab 2000;85:3541-3.
4. Silverberg S, Vitamin D. Deficiency and primary hyperparathyroidism. J Bone Miner Res 2007;22:100-4.
5. Augustine MM, Bravo PE, Zeiger MA. Surgical treatment of primary hyperparathyroidism. Endocr Pract 2011;17:75-82.
6. Morita SY, Somervell H, Umbricht CB, et al. Evaluation for concomitant thyroid nodules and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy. Surgery 2008;144:842-6.
7. Mittendorf EA, Merlino JI, McHenry CR. Postparathyroidectomy hypocalcemia: incidence, risk factors, and management. Am J Surg 2004;70:114-9.
8. Westerdahl J, Lincblom P, Valdemarsson S, et al. Risk factors for postoperative hypocalcemia after surgery for primary hyperparathyroidism. Arch Surg 2000;135:142-7.
9. Kald BA, Mollerup CL. Risk factors for severe postoperative hypocalcaemia after operations for primary hyperparathyroidism. Eur J Surg 2002;168:552-6.
10. Strickland PL, Racabaren J. Are postoperative serum calcium, parathyroid hormone, and adenoma weight predictive of postoperative hypocalcemia? Am J Surg 2002;68:1080-2.
11. Beckerman P, Silver J. Vitamin D and the parathyroid. Am J Med Sci 1999;317:363-9.
12. Carling T, Rastad J, Szabo E, et al. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. J Clin Endocrinol Metab 2000;85:2000-3.
13. Erbil Y, Bozbora A, Ozbey N, et al. Predictive value of age and serum parathormone and vitamin D3 levels for postoperative hypocalcemia after total thyroidectomy for nontoxic multinodular goiter. Arch Surg 2007;142:1182-7.
14. Segersten U, Correa P, Hewison M, et al. 25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands. J Clin Endocrinol Metab 2002;87:2967-72.
15. Rao DS, Honasoge M, Divine GW, et al. Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab 2000;85:1054-8.
16. Raef H, Ingemanson S, Sobhi S, et al. The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism in a vitamin D deficient region. J Endocrinol Invest 2004;27:807-12.
17. Boudou P, Ibrahim F, Cormier C, et al. A very high incidence of low 25 hydroxyvitamin D serum concentration in a French population of patients with primary hyperparathyroidism. J Endocrinol Invest 2006;29:511-5.
18. Stewart ZA, Blackford A, Somervell H, et al. 25-hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy. Surgery 2005;138:1018-26.
19. Silverberg SJ, Shane E, Dempster DW, et al. The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med 1999;107:561-7.
20. Tsiaras WG, Weinstock MA. Factors influencing vitamin D status. Acta Derm Venereol 2011;91:115-24.